Clinical Trial Update: Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of pazopanib monotherapy in advanced non-small cell lung cancer was terminated, with results posted in January 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pazopanib (Votrient) (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 2 | Status: TERMINATED | Results posted: 2010-01-27